Please login to the form below
constipation
This page shows the latest constipation news and features for those working in and with pharma, biotech and healthcare.
Immunology keeps Shire figures solid as Takeda takeover nears
HAE, prucalopride (SHP555) for chronic idiopathic constipation, and calaspargase pegol (SHP663) for the treatment of acute lymphoblastic leukaemia (ALL).
Latest news
-
Mallinckrodt pays $1.2bn for Sucampo Pharma
As 2017 drew to a close, Mallinckrodt signed a deal to buy Sucampo Pharma of the US - and its constipation drug Amitizia - for $1.2bn. ... Amitizia is the prize asset in the deal, with FDA approvals in hand for three indications - chronic idiopathic
-
NICE backs Allergan's IBS therapy Truberzi
includes Linzess (linaclotide) for IBS with constipation.
-
FDA fast-tracks Pfizer and Lilly's tanezumab
unpleasant side effects such as severe constipation.
-
FDA approves Synergy's constipation drug Trulance
Synergy Pharma is celebrating after the FDA approved Trulance, its drug for the treatment of chronic idiopathic constipation (CIC) in adults. ... There are around 42 million people in the US who suffer from constipation, according to the National
-
Valeant's proposed sale of Salix to Takeda 'in jeopardy'
That push will also extend to opioid-induced constipation drug Relistor (methylnaltrexone bromide), and comments made by the company in its announcement lend some credence to the rumours of the breakdown
More from news
Approximately 9 fully matching, plus 76 partially matching documents found.
Latest Intelligence
-
Erectile dysfunction, constipation, vaginal dryness and other laughing matters
Erectile dysfunction, constipation, vaginal dryness and other laughing matters. Humour in healthcare brand communications: when and where is it appropriate? ... Diarrhoea, constipation, flatulence, leaky bladder, vaginal dryness - it’s all fertile
-
Taking a lean and careful approach
His pioneering research culminated in the drug, Trulance, which has received FDA approval and is being used to treat irritable bowel syndrome and chronic constipation.
-
Deal Watch March 2016
$110. AstraZeneca/ Kyowa Hakko Kirin. Opioid-induced constipation – Moventig. Licence. $70.
-
Oral biologics delivery still elusive
years. Among a newer generation of orally-delivered peptides is Ironwood Pharma's peptide drug Linzess/Constella (linaclotide) - which debuted in 2012 for constipation associated with irritable bowel syndrome.
-
Medius Deal Watch table for March 2015
941. AstraZeneca / Daiichi Sankyo. Co-commercialisation US . Marketed Movantik (naloxegol) for opioid induced constipation.
More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.
Latest appointments
-
Ironwood appoints Edward Owens to board
irritable bowel syndrome and constipation. “
-
Norgine’s Karen Hockey promoted to head of global marketing
Norgine’ s Karen Hockey promoted to head of global marketing. Appointment follows nearly two years as global brand manager for constipation treatment Movicol. ... Hockey's promotion comes after nearly two years as global brand manager for constipation
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
Opioid-Induced Constipation (OIC) Treatment Market: Key Trends and Forecast Research Report 2016-2026
Opioid-Induced Constipation (OIC) Treatment Market: Key Trends and Forecast Research Report 2016-2026. ... Future Market Insights has announced the addition of the “ Opioid-Induced Constipation (OIC) Treatment Market: Global Industry Analysis and
-
FCB Halesway
Stroke prevention in atrial fibrillation. Galen. Branded generics. Constipation. Vitamin D supplements.
More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.
Featured jobs
-
New Business Director - PR
-
Competitive Salary and benefits
- Director, Market Access / HEOR - North-West
-
Negotiable
-
Associate Medical Director
-
Highly Competitive
-
Senior Medical Writer
-
Competitive Salary
-
Consumer Health Account Director
-
Circa £60, 000 Gym and More
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
-
SENIOR MEDICAL WRITER IN ONCOLOGY
-
Up to £60, 000.00 pension bonus
- Events Manager – Med Comms – Surrey
-
Salary TBC
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
- Account Manager, Healthcare Public Affairs
-
£32, 000 – £40, 000 benefits
-
Medical Writers
-
Competitive Salary and Benefits
-
Account Director
-
£48, 000 - £60, 000
-
Medical/ Scientific Director
-
Salary TBC
- Programme Director, Healthcare PR, Highly competitive package
-
Highly Competitive package
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
-
Account Director
-
Excellent benefits
-
Associate Director
-
£75, 000-90, 000
Subscribe to our email news alerts
PMHub
Apex.co.uk Conferences, Events and Exhibition Stands
Apex.co.uk is one of the UK’s leading event and exhibition agencies, specialising in healthcare. We understand your communication goals, whether...
Latest intelligence
- World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
- Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
- World Diabetes Day: Interaction and impact of diabetes on mental health
- For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
- Innovation in merger control and the impact on the pharmaceutical sector
- Is focusing on pipeline products enough to assess regulatory risks?...
Quick links
Infographics
